5.36
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$5.66
Offen:
$5.55
24-Stunden-Volumen:
10.84M
Relative Volume:
1.24
Marktkapitalisierung:
$833.73M
Einnahmen:
$3.43B
Nettoeinkommen (Verlust:
$-2.46B
KGV:
-0.2677
EPS:
-20.0187
Netto-Cashflow:
$-204.10M
1W Leistung:
-35.50%
1M Leistung:
-46.88%
6M Leistung:
-69.11%
1J Leistung:
-81.85%
Fmc Corp Stock (FMC) Company Profile
Firmenname
Fmc Corp
Sektor
Branche
Telefon
215-299-6668
Adresse
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs NTR, CF, CTVA, ICL, MOS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
FMC
Fmc Corp
|
5.36 | 833.73M | 3.43B | -2.46B | -204.10M | -20.02 |
|
NTR
Nutrien Ltd
|
69.44 | 33.14B | 27.83B | 2.42B | 2.21B | 4.9113 |
|
CF
Cf Industries Holdings Inc
|
118.51 | 17.94B | 7.41B | 2.12B | 1.62B | 11.13 |
|
CTVA
Corteva Inc
|
12.65 | 8.44B | 17.89B | 1.26B | 2.05B | 1.7029 |
|
ICL
Icl Group Ltd
|
4.88 | 6.30B | 7.41B | 314.00M | 220.88M | 0.202 |
|
MOS
Mosaic Company
|
17.92 | 5.70B | 12.43B | 70.90M | -489.30M | 0.1275 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-16 | Herabstufung | Jefferies | Buy → Hold |
| 2026-09-11 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2026-04-22 | Herabstufung | Vertical Research | Hold → Sell |
| 2025-12-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-31 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-23 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-25 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2025-02-14 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-07 | Herabstufung | UBS | Buy → Neutral |
| 2025-02-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-21 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-01-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-23 | Eingeleitet | Citigroup | Neutral |
| 2024-06-26 | Eingeleitet | Barclays | Equal Weight |
| 2024-03-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-02-12 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-01-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-01-04 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-12-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-10-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-24 | Herabstufung | Goldman | Buy → Neutral |
| 2023-10-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-09-25 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-21 | Eingeleitet | JP Morgan | Neutral |
| 2023-08-04 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2023-07-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-17 | Hochstufung | Redburn | Neutral → Buy |
| 2023-01-19 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-07-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-06-21 | Hochstufung | BofA Securities | Underperform → Buy |
| 2022-06-13 | Herabstufung | Redburn | Buy → Neutral |
| 2022-05-31 | Eingeleitet | Credit Suisse | Underperform |
| 2022-04-14 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-03-31 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-03-22 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-10 | Bestätigt | Citigroup | Buy |
| 2022-02-10 | Bestätigt | Mizuho | Buy |
| 2022-02-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-02-10 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-31 | Eingeleitet | Redburn | Buy |
| 2022-01-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-10-18 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-24 | Herabstufung | Vertical Research | Buy → Hold |
| 2021-05-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-02-11 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-09-17 | Eingeleitet | UBS | Buy |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-10-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-16 | Eingeleitet | Wells Fargo | Outperform |
| 2019-09-18 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-08-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-08-02 | Hochstufung | Goldman | Neutral → Buy |
| 2019-08-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-13 | Fortgesetzt | Citigroup | Buy |
| 2019-05-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-04-18 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-03-21 | Bestätigt | Jefferies | Buy |
| 2019-03-08 | Fortgesetzt | Goldman | Neutral |
| 2018-11-14 | Eingeleitet | Buckingham Research | Buy |
| 2018-11-09 | Fortgesetzt | Loop Capital | Buy |
| 2018-11-05 | Fortgesetzt | Citigroup | Buy |
| 2018-11-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-05-14 | Hochstufung | Goldman | Neutral → Buy |
| 2018-05-04 | Hochstufung | Stephens | Equal-Weight → Overweight |
Alle ansehen
Fmc Corp Aktie (FMC) Neueste Nachrichten
Why FMC Corporation Stock Just Crashed - The Motley Fool
FMC Maintained by Mizuho -- Price Target Lowered to $12.00 - GuruFocus
FMC Corporation: The Shorts Have A Point (NYSE:FMC) - Seeking Alpha
UBS Initiates FMC Corp(FMC.US) With Hold Rating, Announces Target Price $10 - Moomoo
FMC Corporation (FMC) options chain - Yahoo Finance Australia
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
FMC Corporation (FMC) Stock forecasts - Yahoo Finance UK
Precision Trading with Fmc Corporation (FMC) Risk Zones - Stock Traders Daily
Did FMC's (FMC) Brazil Rimisoxafen Filing Just Shift Its Crop Protection Investment Narrative? - Yahoo! Finance Canada
Did FMC's (FMC) Brazil Rimisoxafen Filing Just Shift Its Crop Protection Investment Narrative? - Yahoo Finance
How Investors May Respond To FMC (FMC) Brazil Herbicide Filing - Simply Wall Street
FMC Corporation (FMC) Stock Forecasts - Yahoo! Finance Canada
Stock Market Today, Oct. 6: Corteva Rallies 12% on Analyst Upgrade Following Spin Off - The Motley Fool
FMC (NYSE:FMC) Looks to Reset Its Crop Protection Strategy - Kalkine Media
FMC completes Tessenderlo deal: FMC Corporation stock sits 71.45 percent below high - AD HOC NEWS
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC Corp. stock rises 6.64 percent ahead of Q3 results - AD HOC NEWS
FMC Corporation Price Target Cut to $10.00/Share From $12.00 by UBS - Moomoo
UBS Adjusts FMC Price Target to $10 From $12, Maintains Neutral Rating - marketscreener.com
FMC Corporation (FMC) Stock forecasts - Yahoo Finance Australia
FMC Corp. stock outperforms competitors despite losses on the day - MarketWatch
FMC Corp. stock after-hours at EUR 7.52: minus 1.31 percent versus prior close - AD HOC NEWS
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
FMCFMC Corp. | News - OTC Markets
FMC Corporation (FMC) Stock Forecasts - Yahoo! Finance Canada
FMC Corporation (FMC) Stock Forecasts - Yahoo Finance
An executive delivers or withholds 5,137 FMC Corp (FMC) shares for exercise-price or tax payments. - Stock Titan
FMC (FMC) Stock May Be Below Fair Value As Stake Deal Closes - Simply Wall Street
Non-controlling/minority interest of FMC Corporation – HAN:FMQ - TradingView
FMC Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
FMC Corp Hired Firms, 2019 - OpenSecrets
Average basic shares outstanding of FMC Corporation – HAN:FMQ - TradingView
FMC files for approval on new herbicide in Brazil - Greenhouse Management
ETFs Investing in FMC Corporation Stocks - TradingView
FMC Submits Rimisoxafen Regulatory Filing for Approval in Brazil - Zacks Investment Research
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil - PR Newswire
FMC Corp Agencies, 2009 - OpenSecrets
Luc Jules R Tack Secures Board Seat at FMC Corporation with 20% Stake - TradingView
A 10% owner can nominate one FMC Corp (FMC) board member. Its shareholding is disclosed. - Stock Titan
A director nominee and board observer follow Tessenderlo's purchase of FMC Corp (NYSE: FMC) shares. - Stock Titan
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
FMC Corporation Stock (FMC) Opinions on Tessenderlo's Strategic Investment - Quiver Quantitative
FMC Corporation (FMC) Stock Forecasts - finance.yahoo.com
FMC Corporation and Tessenderlo Group Complete Minority Equity Investment - PR Newswire
FMC Corporation (FMC) Sells 20% Stake to Tessenderlo for $403M - TradingView
FMC Corporation and Tessenderlo Group Complete Minority Equity Investment - morning-times.com
FMC Corp stock holds near its yearly low - AD HOC NEWS
FMC (FMC) Stock Looks Cheap Against Sales After Its 87% Fall - Yahoo Finance UK
FMC (FMC) Stock Looks Cheap Against Sales After Its 87% Fall - finance.yahoo.com
Finanzdaten der Fmc Corp-Aktie (FMC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fmc Corp-Aktie (FMC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pfeiffer Nicholas | Officer |
Sep 09 '26 |
Proposed Sale |
12.78 |
1,251 |
15,982 |
0 |
| BARRY MICHAEL F | Director |
Mar 04 '26 |
Buy |
13.83 |
18,072 |
249,938 |
19,634 |
| Raines John Mitchell | Director |
Nov 13 '25 |
Buy |
13.77 |
7,000 |
96,390 |
13,784 |
| DAVIDSON CAROL ANTHONY | Director |
Nov 05 '25 |
Buy |
13.60 |
10,000 |
135,957 |
23,227 |
| Scanlan Jacqueline | Executive VP & Chief HRO |
Sep 29 '25 |
Sale |
34.00 |
3,790 |
128,860 |
33,044 |
| Scanlan Jacqueline | Officer |
Sep 29 '25 |
Proposed Sale |
34.00 |
3,790 |
128,860 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):